Literature DB >> 26864592

Vismodegib and Physeal Closure in a Pediatric Patient.

John T Lucas1, Karen D Wright2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26864592      PMCID： PMC8717212          DOI： 10.1002/pbc.25941

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  1 in total

1.  Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.

Authors:  Amar Gajjar; Clinton F Stewart; David W Ellison; Sue Kaste; Larry E Kun; Roger J Packer; Stewart Goldman; Murali Chintagumpala; Dana Wallace; Naoko Takebe; James M Boyett; Richard J Gilbertson; Tom Curran
Journal:  Clin Cancer Res       Date:  2013-09-27       Impact factor: 12.531
  1 in total
  4 in total

1.  Hedgehog signaling drives medulloblastoma growth via CDK6.

Authors:  David R Raleigh; Pervinder K Choksi; Alexis Leigh Krup; Wasima Mayer; Nicole Santos; Jeremy F Reiter
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

2.  Exogenous Indian hedgehog antagonist damages intervertebral discs homeostasis in adult mice.

Authors:  Ran Chen; Ya Tan; Yang Li; Junlan Huang; Liang Kuang; Zhenhong Ni; Haiyang Lan; Rui Long; Yangli Xie; Hangang Chen; Xiaoqing Luo; Lin Chen; Ying Tang; Siru Zhou
Journal:  J Orthop Translat       Date:  2022-10-06       Impact factor: 4.889

3.  Cilia-Associated Oxysterols Activate Smoothened.

Authors:  David R Raleigh; Navdar Sever; Pervinder K Choksi; Monika Abedin Sigg; Kelly M Hines; Bonne M Thompson; Daniel Elnatan; Priyadarshini Jaishankar; Paola Bisignano; Francesc R Garcia-Gonzalo; Alexis Leigh Krup; Markus Eberl; Eamon F X Byrne; Christian Siebold; Sunny Y Wong; Adam R Renslo; Michael Grabe; Jeffrey G McDonald; Libin Xu; Philip A Beachy; Jeremy F Reiter
Journal:  Mol Cell       Date:  2018-10-18       Impact factor: 17.970

4.  Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor.

Authors:  Giles W Robinson; Sue C Kaste; Wassim Chemaitilly; Daniel C Bowers; Stephen Laughton; Amy Smith; Nicholas G Gottardo; Sonia Partap; Anne Bendel; Karen D Wright; Brent A Orr; William C Warner; Arzu Onar-Thomas; Amar Gajjar
Journal:  Oncotarget       Date:  2017-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.